Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene ATM
Variant N2875H
Impact List missense
Protein Effect unknown
Gene Variant Descriptions ATM N2875H lies within the PI3K/PI4K domain of the Atm protein (UniProt.org). N2875H has been identified in the scientific literature (PMID: 26510020), but has not been biochemically characterized and therefore, its effect on Atm protein function is unknown (PubMed, Jun 2024).
Associated Drug Resistance
Category Variants Paths

ATM mutant ATM N2875H

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000051.4
gDNA chr11:g.108347317A>C
cDNA c.8623A>C
Protein p.N2875H
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_017017790.2 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_011542840.3 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
NM_000051.4 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_011542843.3 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_011542840.4 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_005271562.6 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_047426976.1 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_011542843.2 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
NM_000051.3 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_006718843.5 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_006718843.4 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_017017789.2 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_005271562.5 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_047426975.1 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
NM_001351834.1 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
NM_001351834.2 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38
XM_017017790.3 chr11:g.108347317A>C c.8623A>C p.N2875H RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
ATM N2875H prostate cancer predicted - sensitive Olaparib Case Reports/Case Series Actionable In a Phase II trial (TOPARP-A), Lynparza (olaparib) treatment resulted in a conversion in the circulating tumor-cell count and an 85% decrease in PSA level in a patient with metastatic castration-resistant prostate cancer harboring ATM N2875H (PMID: 26510020; NCT01682772). 26510020